Intractable Ventricular Tachycardia Prior to an Overt Cardiac Tumor Mass of Metastatic Cardiac Rhabdomyosarcoma (Spindle-cell Type).

Cardiac sarcoma Cardio-oncology Rhabdomyosarcoma Ventricular tachycardia

Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
06 Nov 2023
Historique:
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 5 11 2023
Statut: aheadofprint

Résumé

We herein report a 37-year-old man who experienced recurrence of metastatic cardiac rhabdomyosarcoma along with intractable ventricular tachycardia (VT) 7 years after resection of rhabdomyosarcoma in his right elbow. At 36 years old, he developed VT unresponsive to radiofrequency catheter ablation (RFCA). Initially, the cardiac tumor was not detected, but it gradually grew in size at the RFCA site. A surgical biopsy confirmed the diagnosis of metastatic cardiac rhabdomyosarcoma. Despite radiation therapy, cardiac tumor progression and VT instability could not be prevented. Ultimately, the patient died 27 months after the initial documentation of VT.

Identifiants

pubmed: 37926544
doi: 10.2169/internalmedicine.2568-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yosuke Terui (Y)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Hideaki Suzuki (H)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Akio Chikata (A)

Department of Cardiology, Toyama Prefectural Central Hospital, Japan.

Yuichi Hanaki (Y)

Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan.

Yuki Komatsu (Y)

Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan.

Hideki Ota (H)

Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, Japan.

Fumiyoshi Fujishima (F)

Department of Pathology, Tohoku University Hospital, Japan.

Rei Umezawa (R)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Japan.

Kota Ouchi (K)

Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Japan.

Haruka Sato (H)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Taijyu Satoh (T)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Saori Miyamichi-Yamamoto (S)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Nobuhiro Yaoita (N)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Hideka Hayashi (H)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Kotaro Nochioka (K)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Hiroyuki Takahama (H)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Akihiko Nogami (A)

Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan.

Yoshikatsu Saiki (Y)

Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, Japan.

Satoshi Yasuda (S)

Departments of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.

Classifications MeSH